quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:17:31·2045d
PRRelease
Cellular Biomedicine Group, Inc. logo
GCI Liberty Inc. logo
Otelco Inc. logo
+1

Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), GCI Liberty, Inc. (NASDAQ: GLIBA), Jernigan Capital, Inc. (NYSE: JCAP), and Otelco Inc. (NASDAQ: OTEL)

CBMG· Cellular Biomedicine Group, Inc.GLIBA· GCI Liberty Inc.OTEL· Otelco Inc.JCAP· Jefferson Capital Inc.
Health CareTelecommunicationsPublic Utilities
Full content unavailable. See the original source below.
Original source

Companies

  • CBMG
    Cellular Biomedicine Group, Inc.
    Health Care
  • GLIBA
    GCI Liberty Inc.
    Telecommunications
  • OTEL
    Otelco Inc.
    Public Utilities
  • JCAP
    Jefferson Capital Inc.
    Finance

Recent analyst ratings

  • Feb 3GLIBAUpdateSeaport Research Partners$68.00
  • Jul 21JCAPUpdateCitizens JMP$23.00
  • Jul 21JCAPUpdateKeefe Bruyette$22.00
  • Jul 21JCAPUpdateJefferies$29.00
  • Jul 21JCAPUpdateTruist$24.00
  • Jul 21JCAPUpdateRaymond James$19.00

Related

  • SEC9h
    Jefferson Capital Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
  • PR18h
    Jefferson Capital Secures Credit Facility Expansion
  • PR1d
    GCI to Acquire Quintillion, Strengthening Alaska's Fiber Infrastructure
  • PR1d
    GCI to Acquire Quintillion, Strengthening Alaska's Fiber Infrastructure
  • SEC2d
    SEC Form DEFA14A filed by Jefferson Capital Inc.
  • SEC2d
    SEC Form DEF 14A filed by Jefferson Capital Inc.
  • PR3d
    Liberty Broadband Corporation to Conduct Quarterly Q&A Conference Call
  • PR3d
    GCI Liberty, Inc. Announces First Quarter Earnings Release and Conference Call
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022